Trupanion (TRUP) Gets a Buy Rating from Canaccord Genuity

In a report released today, Maria Ripps from Canaccord Genuity maintained a Buy rating on Trupanion (TRUPResearch Report), with a price target of $42.00. The company’s shares closed last Thursday at $29.91.

According to, Ripps is a 3-star analyst with an average return of 2.0% and a 50.0% success rate. Ripps covers the Technology sector, focusing on stocks such as Spotify Technology SA, Zillow Group, and Leaf Group.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Trupanion with a $41.50 average price target, a 30.9% upside from current levels. In a report issued on April 23, RBC Capital also maintained a Buy rating on the stock with a $39.00 price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $38.07 and a one-year low of $20.85. Currently, Trupanion has an average volume of 424.9K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the following segments: Subscription Business and Other Business. The Subscription Business segment involves in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members and contracts include multiple pets. The company was founded by Darryl Rawlings in January 2000 and is headquartered in Seattle, WA.